Bolt Biotherapeutics Inc. (NASDAQ: BOLT) Stock Information | RedChip

Bolt Biotherapeutics Inc. (NASDAQ: BOLT) Listen to this Section


$0.70
+0.0074 ( +1.07% ) 43.8K

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Market Data


Open


$0.70

Previous close


$0.69

Volume


43.8K

Market cap


$26.35M

Day range


$0.69 - $0.70

52 week range


$0.65 - $1.56

Insider Ownership Transactions

Total Amount Purchased: -799,000.00 | $ -557,222.60

Date Type Amount Purchased Purchaser
2024-07-24 Sale -50000.00 Nemec Sarah
2024-07-24 Sale -440000.00 Quinn William P.
2024-07-24 Sale -155000.00 Yonehiro Grant
2024-06-14 Sale -22000.00 ONETTO NICOLE
2024-06-14 Sale -22000.00 O'CALLAGHAN BRIAN
2024-06-14 Sale -22000.00 Lee Frank D.
2024-06-14 Sale -22000.00 LAPORTE KATHLEEN
2024-06-14 Sale -22000.00 HEALY JAMES
2024-06-14 Sale -22000.00 Berner Laura
2024-06-14 Sale -22000.00 SHAH MAHENDRA

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Aug 13, 2024
10-q Quarterly Reports 55 Aug 13, 2024
4 Insider transactions 1 Jul 24, 2024
4 Insider transactions 1 Jul 24, 2024
4 Insider transactions 1 Jul 24, 2024
8-k 8K-related 13 Jul 03, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.